American Journal of Clinical Oncology · 2006 · 15 citations · 19 references
MedicineOncologyHead OncologyMolecular OncologyNeoplasiaCancer BiomarkersCancer Survival AnalysisTelomere BiologyClinicopathologic FeaturesClinicopathological CorrelationKaplan-meier Confidence IntervalsPearson Chi-square TestTelomerase Activity AssessmentTelomerase EnzymeTelomerase FunctionTelomere Biomarkers In Cancer
OBJECTIVE: This study investigates the expression of telomerase in the peripheral blood mononuclear cells (PBMCs) of head and neck cancer patients and the relationship between the telomerase expression in PBMCs and clinicopathological features with prognosis. METHODS: Peripheral blood samples were collected from 100 head and neck squamous cell cancer patients and 20 normal control group. The telomerase activity in peripheral blood mononuclear cells was measured by telomerase rapid amplification protocol (TRAP) assay using TRAPeze telomerase detection kit. Pearson chi test was used to analyze the correlation of telomerase expression with clinicopathologic parameters. Kaplan-Meier method and Cox proportional hazards model were used for prognostic analysis. RESULTS: Regarding the expression of telomerase in PBMCs of patients, 73 out of 100 (73.0%) were found to be positive, and the remaining 27 cases (27.0%) were negative. The difference to the telomerase expression of PBMCs in the normal and cancer patients was significant (P < 0.001). The expression of telomerase in PBMCs of patients was significant correlated with T classification (P = 0.005), N classification (P = 0.002), and AJCC stages (P < 0.001). On multivariate analysis, N classification (P = 0.007), AJCC stages (P = 0.02), and telomerase expression (P = 0.017) showed independent factors associated with poor survival. CONCLUSION: The detection of telomerase expression in PBMCs of head and neck cancer patients is a simple and very useful molecular marker for the progression and prognosis of head and neck cancer.
19
Specific Association of Human Telomerase Activity with Immortal Cells and Cancer
Nam W. Kim, Mieczyslaw A. Piatyszek, Karen R. Prowse et al. · Science · 1994 · 7.1K citations
Prognostic value of proliferating cell nuclear antigen in gastric carcinoma.
Sunjay Jain, M. I. Filipe, Peter A. Hall et al. · Journal of Clinical Pathology · 1991 · 188 citations · Full text
Naokuni Tatsumoto, Eiso Hiyama, Yoshiaki Murakami et al. · PubMed · 2000 · 133 citations